GenomeKey raise Innovate UK funding to drive life-saving next-gen sepsis diagnostic

Posted by 

SETsquared Bristol

Our member GenomeKey, has secured an Innovate UK Biomedical Catalyst research award of £950,000 towards faster diagnosis and treatment of sepsis, one of the world’s most deadly diseases.

The funding will enable the Bristol-based research and development company to provide rapid bacterial species identification and antimicrobial profiling in the hospital, which will save lives, save money, and save our antibiotics for the future.

The biotech company have raised £3.8 million to date in equity and non-dillutive funding sources.

Michael Roberts, CEO of GenomeKey said:

“Sepsis kills one in five people globally every year, and many of these deaths occur due to antibiotic resistance. GenomeKey believes in a future where these deaths can be avoided.

This project will enable us to get GenomeKey’s diagnostic for rapid bacterial species and antibiotic resistance identification closer to the people who need it, by placing our technology onto a portable microfluidic chip. We look forward to working with Innovate UK Biomedical Catalyst towards this goal.”

Recent News, Blogs and Stories

Siloton founders, 2 men wearing blue shirts in front of trees

Siloton co-founders awarded Institute of Physics’ Clifford Paterson Medal

Dr Alasdair Price and Dr Euan Allen, Co-founders of healthtech startup Siloton, have been awarded the Institute of Physics’ Clifford Paterson Medal for ‘exceptional early-career contributions to the application of...
Enterprising Women 3.0 group

Inspiring women founders pitch at Enterprising Women finale 

We were delighted to showcase 18 women-led startups on our Enterprising Women 3.0 pre-incubation programme last week.   The evening, kindly hosted at TLT in Bristol, brought an inspirational group of...
Moropo founders with demo

Moropo releases innovative app testing tool

Bristol tech company Moropo has launched a new mobile app testing tool for software agencies and startups. The web-based automation platform comprises a low-code test creator, a test scheduling system...


Fast track your technology business